Cromos Pharma’s CEO to Present at the 17th BioPharma Nexus Conference Cromos Pharma’s CEO to present at the 17th BioPharma Nexus Conference, which is set to take place June 15-16, 2023 in Amsterdam, Netherlands. Cromos Pharma’s CEO Vlad Bogin, MD, FACP will be participating as a speaker in the panel discussion “How to put Patients in the Heart of Clinical Trials & Daily Practice?”. Vlad is looking forward to meeting partners
FDA Encourages the Use of Decentralized Clinical Trials in New Draft Guidance On May 2, 2023, the U.S. Food and Drug Administration (FDA) has issued a novel Draft Guidance to further support the use of decentralized clinical trials (DCTs) for drugs, biological products, and devices. This guidance has recommendations for sponsors, investigators and other industry stakeholders regarding the implementation of DCTs to advance medical product development and research. DCTs
Revision of the EU Pharmaceutical Legislation: the Changes Are Major and the Impact Will Be Significant On April 24, 2023, in its first major revision of the EU pharmaceutical legislation in over 20 years the Commission is proposing the most ambitious changes that will have a lasting impact on the drug industry. The reform includes two legislative proposals: a new Directive and a new Regulation which establish the EU regulatory framework
